Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function (Q40850940)

24 September 2017

Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

Jenne L

1

1 reference

24 September 2017

Hauser C

2

1 reference

24 September 2017

Arrighi JF

3

1 reference

24 September 2017

Saurat JH

4

1 reference

24 September 2017

Hügin AW

5

1 reference

24 September 2017

1 September 2000

1 reference

24 September 2017

1 reference

24 September 2017

7

1 reference

24 September 2017

18

1 reference

24 September 2017

1575-1583

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301287

24 September 2017

0 references

cites work

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Applications of pox virus vectors to vaccination: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Poxviruses as expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Nonreplicating vaccinia vector efficiently expresses recombinant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Dendritic cells are potent antigen-presenting cells for microbial superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Structure of vaccinia virus early promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Vaccinia virus immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301287

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301287

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference